ChEMBL is a database of bioactive, drug-like compounds and the biological targets they interact with, and connecting it through Neotask lets an agent search that data directly in conversation. Ask about a specific compound and the agent can look up its binding data, its mechanism of action, or its ADMET properties, referring to absorption, distribution, metabolism, excretion, and toxicity. You can also search the other direction, starting from a target protein and asking which compounds are known to act against it based on recorded bioactivity. This suits researchers who are used to querying ChEMBL directly but want a faster path to a specific fact, whether that's confirming a mechanism, comparing a handful of compounds against the same target, or pulling bioactivity figures without opening ChEMBL's own search interface each time a question comes up during a review, which adds up when several compounds or targets need checking in the same sitting.
| Compound search | Finds a bioactive, drug-like compound in ChEMBL by name or identifier |
| Target lookup | Retrieves biological target information and finds compounds associated with a named target |
| Binding data query | Returns binding data for a compound against a specific target |
| Mechanism of action lookup | Reports the known mechanism of action recorded for a compound |
| ADMET data retrieval | Pulls absorption, distribution, metabolism, excretion, and toxicity data for a compound |
| Bioactivity comparison | Compares bioactivity data for multiple compounds against the same target |
A researcher exploring candidates against a specific target protein asks their Neotask agent to list known compounds in ChEMBL with recorded bioactivity against it. The agent returns a set of compounds along with their binding data, letting the researcher shortlist candidates for further review before running any lab work, which saves an initial round of manual searching in ChEMBL's own interface. The researcher then asks the agent to compare ADMET profiles across the shortlisted set, narrowing the list further before deciding which compounds are worth pursuing in the lab. What began as a broad question about a single target ends with a short, ranked list ready for the next stage of review.
Before citing a compound's mechanism in a paper draft, a researcher asks the agent to confirm what ChEMBL records for that compound's mechanism of action and ADMET profile. The agent pulls both from ChEMBL and reports them together, giving the researcher a quick check against the database before finalizing the citation for submission. Because the answer comes back in the same conversation as the draft, the researcher can adjust the wording immediately rather than making a note to check it later and possibly forgetting.
Bioactive, drug-like compounds along with the biological targets they interact with, which is what the agent searches when you ask about a specific compound or target. That scope matches what ChEMBL itself is built to catalog.
Yes, you can ask which compounds have known bioactivity against a specific target protein and the agent will search ChEMBL from that direction instead, returning the matching compounds it finds.
Absorption, distribution, metabolism, excretion, and toxicity data recorded in ChEMBL for the compound you ask about, returned together in one answer rather than as separate lookups.
No, it's a faster way to query ChEMBL's recorded data. Confirming findings against original studies is still worthwhile for anything going into a formal analysis or publication, especially where the stakes of being wrong are high, and the underlying papers often contain context a database entry alone won't show.
Yes, you can ask it to compare bioactivity data for several compounds against the same target and it will return the relevant figures for each one side by side, which is faster than running the same comparison one compound at a time in ChEMBL's own interface.
Researchers and others working with drug-like compounds and target proteins who want to query ChEMBL's binding, mechanism, and ADMET data directly in conversation instead of the web interface, especially during early screening or literature checks.